The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Targeting Nonhealing Ulcers of Lower Extremity in Human Through Autologous Bone Marrow-Derived Mesenchymal Stem Cells
Abstract
Bone marrow (BM)-derived mesenchymal stem cells (MSCs) represent a promising population for supporting new concepts in cellular therapy. This study was undertaken to assess the efficacy and feasibility of autologous BM-derived MSCs in the treatment of chronic nonhealing ulcers (diabetic foot ulcers and Buerger disease) of the lower extremities. A total of 24 patients with nonhealing ulcers of the lower limb were enrolled and randomized into implant and control groups. In the implant group, the patients received autologous cultured BM-derived MSCs along with standard wound dressing; the control group received only the standard wound dressing regimen, followed up for at least a 12-week period. Wound size, pain-free walking distance, and biochemical parameters were measured before therapy and at every 2-week interval following intervention. The implant group had significant improvement in pain-free walking distance and reduction in ulcer size as compared to those in the control group. In the implant group for Buerger disease, the ulcer area decreased from 5.04 ± 0.70 cm 2 to 1.48 ± 0.56 cm 2 ( p < 0.001), whereas the pain-free walking distance increased from 38.33 ± 17.68 m to 284.44 ± 212.12 m ( p < 0.001). In the diabetic foot ulcer group, the ulcer size decreased from 7.26 ± 1.41 cm 2 to 2 ± 0.98 cm 2 ( p < 0.001) at 12 weeks. Mononuclear cells were cultured for a minimum of five passages and characterized by cell-surface markers showing CD90 + , CD105 + , and CD34 − . There was no significant alteration in the biochemical parameters observed during the follow-up period, indicating normal liver and renal function following intervention. Biopsy microsection of implanted tissues showed development of dermal cells (mainly fibroblasts), including mature and immature inflammatory cells. The study indicates that autologous implantation of BM-derived MSCs in nonhealing ulcers accelerates the healing process and improves clinical parameters significantly.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Along these lines, clinical studies have shown that bone marrow– and adipose tissue–derived MSCs can augment the repair process when applied locally to chronic skin wounds in patients (96, 150).”
From Wound repair and regeneration: Mechanisms, signaling, and translation (2014) · cites this paper as [150]
Citations
Cites
Multilineage potential of adult human mesenchymal stem cells
Pittenger, M. F., Mackay, A. M., Beck, S. C., Jaiswal, R. K., Douglas, R., Mosca, J. D., Moorman, M. A., Simonetti, D. W., Craig, S., & Marshak, D. R. (1999) · Science · doi:10.1126/science.284.5411.143 · Cited by 21,052
Singer, A. J., & Clark, R. A. F. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909023411006 · Cited by 6,106
Wound Healing--Aiming for Perfect Skin Regeneration
Martin, P. B. (1997) · Science · doi:10.1126/science.276.5309.75 · Cited by 4,842
Horwitz, E. M., Blanc, K. L., Dominici, M., Mueller, I., Slaper‐Cortenbach, I., Marini, F. C., Deans, R. J., Krause, D. S., & Keating, A. (2005) · Cytotherapy · doi:10.1080/14653240500319234 · Cited by 2,071
Horwitz, E. M., Gordon, P. L., Koo, W. K. K., Marx, J. C., Neel, M. D., McNall, R. Y., Muul, L., & Hofmann, T. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.132252399 · Cited by 1,650
Blanc, K. L., Tammik, L., Sundberg, B., Haynesworth, S. E., & Ringdén, O. T. H. (2003) · Scandinavian Journal of Immunology · doi:10.1046/j.1365-3083.2003.01176.x · Cited by 1,367
Mesenchymal Stem Cells Can Be Differentiated Into Endothelial Cells In Vitro
Oswald, J., Boxberger, S., Jørgensen, B., Feldmann, S., Ehninger, G., Bornhäuser, M., & Werner, C. (2004) · Stem Cells · doi:10.1634/stemcells.22-3-377 · Cited by 1,318
Kinnaird, T. D., Stabile, E., Burnett, M. S., Shou, M., Lee, C. W., Barr, S., Fuchs, S., & Epstein, S. E. (2004) · Circulation · doi:10.1161/01.cir.0000124062.31102.57 · Cited by 1,304
Koç, O. N., Gerson, S. L., Cooper, B., Dyhouse, S. M., Haynesworth, S. E., Caplan, A. I., & Lazarus, H. M. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.2.307 · Cited by 1,119
Kamihata, H., Matsubara, H., Nishiue, T., Fujiyama, S., Tsutsumi, Y., Ozono, R., Masaki, H., Mori, Y., Iba, O., Tateishi, E., et al. (2001) · Circulation · doi:10.1161/hc3501.093817 · Cited by 948
Falanga, V., Iwamoto, S., Chartier, M., Yufit, T., Butmarc, J., Kouttab, N., Shrayer, D., & Carson, P. (2007) · Tissue Engineering · doi:10.1089/ten.2006.0278 · Cited by 783
Science, medicine, and the future: Healing chronic wounds
Harding, K. G. (2002) · BMJ · doi:10.1136/bmj.324.7330.160 · Cited by 615
Treatment of Chronic Wounds With Bone Marrow–Derived Cells
Badiavas, E. V. (2003) · Archives of Dermatology · doi:10.1001/archderm.139.4.510 · Cited by 469
Rissanen, T. T., Markkanen, J. E., Gruchała, M., Heikura, T., Puranen, A., Kettunen, M. I., Kholová, I., Kauppinen, R. A., Achen, M. G., Stacker, S. A., et al. (2003) · Circulation Research · doi:10.1161/01.res.0000073584.46059.e3 · Cited by 442
Dor, Y., Djonov, V., Abramovitch, R., Itin, A., Fishman, G. I., Carmeliet, P., Goelman, G., & Keshet, E. (2002) · The EMBO Journal · doi:10.1093/emboj/21.8.1939 · Cited by 389
Huang, P., Li, S., Han, M., Xiao, Z., Yang, R., & Han, Z. (2005) · Diabetes Care · doi:10.2337/diacare.28.9.2155 · Cited by 351
Higashi, Y., Kimura, M., Hara, K., Noma, K., Jitsuiki, D., Nakagawa, K., Oshima, T., Chayama, K., Sueda, T., Goto, C., et al. (2004) · Circulation · doi:10.1161/01.cir.0000121427.53291.78 · Cited by 230
Postnatal bone marrow stromal cells elicit a potent VEGF-dependent neoangiogenic response in vivo
Al-Khaldi, A., Eliopoulos, N., Martineau, D., Lejeune, L., Lachapelle, K. J., & Galipeau, J. (2003) · Gene Therapy · doi:10.1038/sj.gt.3301934 · Cited by 211
Al-Khaldi, A., Al-Sabti, H. A., Galipeau, J., & Lachapelle, K. J. (2003) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(02)04291-1 · Cited by 203
The future of recombinant growth factors in wound healing
Robson, M. C., Mustoe, T. A., & Hunt, T. K. (1998) · The American Journal of Surgery · doi:10.1016/s0002-9610(98)00186-x · Cited by 200
Kawate, K., Yajima, H., Ohgushi, H., Kotobuki, N., Sugimoto, K., Ohmura, T., Kobata, Y., Shigematsu, K., Kawamura, K., Tamai, K., et al. (2006) · Artificial Organs · doi:10.1111/j.1525-1594.2006.00333.x · Cited by 160
Stem/progenitor cells derived from adult tissues: potential for the treatment of diabetes mellitus
Lechner, A., & Habener, J. F. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00393.2002 · Cited by 132
Isolation of Bone Marrow Stromal Cell–Derived Smooth Muscle Cells by a Human SM22α Promoter
Kashiwakura, Y., Katoh, Y., Tamayose, K., Konishi, H., Takaya, N., Yuhara, S., YAMADA, M., Sugimoto, K., & Daida, H. (2003) · Circulation · doi:10.1161/01.cir.0000070082.64414.b5 · Cited by 122
Ishida, A., Ohya, Y., Sakuda, H., Ohshiro, K., Higashiuesato, Y., Nakaema, M., Matsubara, S., Yakabi, S., Kakihana, A., Ueda, M., et al. (2005) · Circulation Journal · doi:10.1253/circj.69.1260 · Cited by 120
Pal, R., Hanwate, M., Jan, M., & Totey, S. M. (2009) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.143 · Cited by 119
Chronic Cutaneous Ulcers: Etiology and Epidemiology.
Phillips, T. J. (1994) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12388556 · Cited by 115
Human bone marrow stromal cells: In vitro expansion and differentiation for bone engineering
Ciapetti, G., Ambrosio, L., Marletta, G., Baldini, N., & Giunti, A. (2006) · Biomaterials · doi:10.1016/j.biomaterials.2006.08.025 · Cited by 105
Mendez, M. V., Stanley, A. C., Phillips, T. J., Murphy, M., Menzoı́an, J. O., & Park, H. (1998) · Journal of Vascular Surgery · doi:10.1016/s0741-5214(98)70030-8 · Cited by 67
Raffetto, J. D., Mendez, M. V., Phillips, T. J., Park, H., & Menzoı́an, J. O. (1999) · The American Journal of Surgery · doi:10.1016/s0002-9610(99)00134-8 · Cited by 57
Bartsch, T., Brehm, M. U., Falke, T., Kögler, G., Wernet, P., & Strauer, B. E. (2005) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-005-1093-2 · Cited by 19
Cited by
Sorted by citations
Wound repair and regeneration: Mechanisms, signaling, and translation
Eming, S. A., Martin, P., & Tomic-Canic, M. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3009337 · Cited by 3,562
Falanga, V., Isseroff, R. R., Soulika, A. M., Romanelli, M., Margolis, D. J., Kapp, S., Granick, M. S., & Harding, K. G. (2022) · Nature Reviews Disease Primers · doi:10.1038/s41572-022-00377-3 · Cited by 1,160
Concise Review: Role of Mesenchymal Stem Cells in Wound Repair
Maxson, S., Lopez, E. A., Yoo, D. S., Danilkovitch‐Miagkova, A., & LeRoux, M. A. (2012) · Stem Cells Translational Medicine · doi:10.5966/sctm.2011-0018 · Cited by 830
Skin tissue engineering: wound healing based on stem-cell-based therapeutic strategies
Dehkordi, A. N., Mirahmadi, F., Chehelgerdi, M., & Dehkordi, S. R. (2019) · Stem Cell Research & Therapy · doi:10.1186/s13287-019-1212-2 · Cited by 561
Mesenchymal stem or stromal cells: a review of clinical applications and manufacturing practices
Sharma, R. R., Pollock, K., Hubel, A., & McKenna, D. H. (2013) · Transfusion · doi:10.1111/trf.12421 · Cited by 439
Metadata
- Authors
- Dash, N. R., Dash, S. N., Routray, P., Mohapatra, S., & Mohapatra, P. C.
- Affiliations
- Sriram Chandra Bhanja Medical College Hospital (IN)
- Central Institute of Freshwater Aquaculture (IN)
- Corresponding author
- Mohapatra, Prakash C.
- Venue
- Rejuvenation Research
- Publisher
- SAGE Publications
- Published
- 2009-10
- Volume
- 12
- Issue
- 5
- Pages
- 359-366
- ISSN
- 1094-5458 (ISSN-L)
- 1549-1684
- 1557-8577
- OpenAlex
- W2018862422
- Cited by
- 339
- References
- 30
- Citations by year
- 2026: 11 · 2025: 11 · 2024: 19 · 2023: 23 · 2022: 35 · 2021: 19 · 2020: 21 · 2019: 17 · 2018: 33 · 2017: 25 · 2016: 20 · 2015: 19 · 2014: 14 · 2013: 27 · 2012: 26
- FWCI
- 15.28
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Rejuvenation Research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Wound Healing and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetic Foot Ulcer Assessment and Management
- Keywords
- mesenchymal stem cells, bone marrow-derived stem cells, autologous cell therapy, chronic non-healing ulcers, diabetic foot ulcer, thromboangiitis obliterans, leg ulcers, wound healing, pain-free walking distance, stem cell transplantation, cell surface markers
- MeSH terms
- Adult, Biopsy, Humans, Inflammation, Leg, Male, Pain, Thromboangiitis Obliterans, Time Factors, Ulcer, Wound Healing, Foot Ulcer, Treatment Outcome, Lower Extremity, Mesenchymal Stem Cell Transplantation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review